Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Retinoblastoma × Mass Screening × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 6 Neoplasms 5 Uterine Cervical Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Dysplasia 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Warts 1 Urinary Bladder Neoplasms 1 Tinea 1 Skin Neoplasms 1 Retinoblastoma 1 Pulmonary Atelectasis 1 Postoperative Complications 1 Pneumonia 1 Oncology Problem 1 Nevus 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Molluscum Contagiosum 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Kidney Failure, Chronic 1 Keratosis, Actinic 1 Intestinal Neoplasms 1 Impetigo 1 Herpes Zoster 1 Head and Neck Neoplasms 1 Erysipelas 1

Interventions

Carboplatin 10 Etoposide 7 Cyclophosphamide 6 Filgrastim 5 Vincristine 4 Topotecan 4 Granulocyte Colony-Stimulating Factor 4 Melphalan 3 Cryotherapy 3 Thiotepa 2 Mesna 2 Ifosfamide 2 Doxorubicin 2 Busulfan 2 racotumomab 1 pegylated granulocyte colony-stimulating factor 1 etoposide phosphate 1 cixutumumab 1 becatecarin 1 alvocidib 1 Ursodeoxycholic Acid 1 Thrombopoietin 1 Thalidomide 1 Sirolimus 1 Simvastatin 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06367569 2024-04-16

TRbFU

Amsterdam UMC, location VUmc

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡